NCT00039767View on ClinicalTrials.gov

Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices

PHASE2CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

April 30, 2006

Conditions
Thrombosis
Interventions
DRUG

Lepirudin

Trial Locations (1)

20892

National Institutes of Health Clinical Center (CC), Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00039767 - Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices | Biotech Hunter | Biotech Hunter